CAR-T Therapy for NHL Treats Concurrent Rheumatic Disease CAR-T Therapy for NHL Treats Concurrent Rheumatic Disease
CAR –T cell therapy for non-Hodgkin lymphoma appeared as safe and effective in patients with rheumatic autoimmune disease as in those without and also improved control of the underlying autoimmunity.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Rheumatology Source Type: news
More News: Allergy | Allergy & Immunology | Autoimmune Disease | Hodgkin's Disease | Lymphoma | Non-Hodgkin's Lymphoma | Rheumatology